Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Single-arm, Non-interventional, Multi-centre Study for Evaluation of Clinical and Patient Reported Outcomes in Adult Patients With CRSwNP on Tezepelumab

NCT07399665 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07399665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07399665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Single-arm, Non-interventional, Multi-centre Study for Evaluation of Clinical and Patient Reported Outcomes in Adult Patients With CRSwNP on Tezepelumab
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
December 25, 2025
Completion date
March 31, 2028
Enrollment
110 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic rhinosinusitis with nasal polyps (crswnp)